營養保健品專用作物市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

2024 年全球營養保健品特種作物市場價值為 218 億美元，預計到 2034 年將以 9.8% 的複合年成長率成長至 566 億美元。

全球預防保健意識的提升以及對天然植物性健康替代方案的日益青睞，推動了這一領域的擴張。包括營養豐富的水果、種子、堅果、蔬菜和藥用草本植物在內的特色作物，因其生物活性和健康益處而備受青睞。這些作物不僅用於功能性食品和膳食補充劑，而且在藥物製劑領域也越來越受歡迎，農業與健康科學的交叉領域日益增多。推動這一趨勢的因素之一是消費者如今將食物視為藥物，並不斷尋求針對性的自然長期健康解決方案。人們對被認為具有增強免疫力或緩解壓力功效的成分的需求持續激增。近年來，全球健康挑戰加劇了這種需求，而精準農業和可控環境栽培等不斷發展的農業技術則維持了這一需求，這些技術實現了全年持續收穫。隨著政府膳食建議和研究機構強調全食物營養，特色作物在營養保健品領域的角色正日益成為全球健康策略的核心。

到2034年，藥用草本植物市場規模將達211億美元。其廣泛應用源自於傳統醫學體係以及日益增多的科學研究驗證。現代消費者越來越傾向於使用草藥療法來緩解壓力、增強免疫力並維持長期健康。這個細分市場持續保持領先地位，這得益於消費者群體對天然產品而非合成產品的偏好以及對植物功效的信賴。一些以提升認知功能、增強活力和增強免疫力而聞名的草藥品種在膳食補充劑領域呈現爆炸性成長，顯著推動了整體市場的擴張。

2024年，膳食補充劑市佔率達到65%，預計到2034年將成長至368億美元。這一成長主要得益於消費者從普通複合維生素轉向針對特定健康目標（例如新陳代謝、大腦功能和運動能力）而設計的植物性配方。成分可追溯性、更清晰的標籤和高生物利用度已成為主要的購買促進因素。領先的膳食補充劑生產商正與特種作物種植者建立策略聯盟，以確保產品品質穩定並建立垂直整合的供應鏈。這有助於確保透明度、永續性和可靠性，而這些正是注重健康的消費者所追求的。

2024年美國營養保健品專用作物市場規模為72億美元，預計2034年將達到141.6億美元。該地區受益於尖端農業技術、強大的研發能力以及成熟的高階保健品市場。華盛頓州、俄勒岡州和加利福尼亞州等州正在大力發展以保健為導向的高價值專用作物種植。對有機農業實踐和永續發展的推動正在加速種植面積的擴張。美國消費者日益注重健康，他們也越來越需要本地種植、可追溯的成分，這為國內種植者創造了機會，使其能夠多元化發展，生產符合高市場標準的植物藥和功能性植物性產品。

營養保健品專用作物市場的主要參與者包括凱敏（Kemin）、紐特拉根醫療保健（Neutragen Healthcare）、美洲中心地帶（Americas Heartland）、艾瑞斯農業（Aries Agro）和嘉吉（Cargill）。這些公司正優先考慮垂直整合，透過直接投資農業合作來確保穩定、高品質的原料供應。許多公司正在利用先進的農業技術，例如受控環境農業（CEA）和精準農業，以確保全年供應並提高產量效率。一項重要的策略重點是開發富含特定生物活性成分的專有作物品種，並與臨床研究緊密結合，以支持其健康聲明。企業正在拓展產品組合，推出針對特定健康目標的清潔標籤、單一成分補充劑。有機、非基因改造和永續農業等認證正被用於差異化產品並建立信任。品牌推廣越來越強調可追溯性，企業也在加大研發投入，以將植物功效與可衡量的健康結果連結起來。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

• 產業生態系分析
  • 供應商格局
  • 利潤率
  • 每個階段的價值增加
  • 影響價值鏈的因素
  • 中斷
• 產業影響因素
  • 成長促進因素
  • 產業陷阱與挑戰
  • 市場機遇
• 成長潛力分析
• 監管環境
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
• 波特的分析
• PESTEL 分析
• 價格趨勢
  • 按地區
• 未來市場趨勢
• 技術與創新格局
  • 當前技術趨勢
  • 新興技術
• 專利格局
• 貿易統計（HS編碼）（註：僅提供重點國家的貿易統計資料）
  • 主要進口國
  • 主要出口國
• 永續性和環境方面
  • 永續實踐
  • 減少廢棄物策略
  • 生產中的能源效率
  • 環保舉措
• 碳足跡考量

第4章：競爭格局

• 介紹
• 公司市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 合作夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章：市場規模及預測：依產品類型分類，2021-2034年

• 主要趨勢
• 藥用草本植物
  • 適應原草藥
  • 傳統藥用植物
  • 抗發炎植物
  • 其他
• 功能性水果和漿果
  • 富含抗氧化劑的莓果
  • 柑橘類水果富含黃酮類化合物
  • 異國水果
• 樹堅果和種子
  • 富含歐米伽的堅果
  • 富含蛋白質的種子
  • 特色堅果
• 烹飪香草和香料
  • 抗發炎香料
  • 芳香草藥
  • 異國香料
• 功能性蔬菜
  • 富含類胡蘿蔔素的蔬菜
  • 十字花科蔬菜
  • 蔥屬蔬菜

第6章：市場規模及預測：依應用領域分類，2021-2034年

• 主要趨勢
• 膳食補充劑
  • 單一成分補充劑
  • 多成分配方
  • 針對特定族群的保健品
• 功能性食品和飲料
  • 添加特種作物萃取物的強化食品
  • 功能飲料
  • 添加益生元特種作物的益生菌食品
• 製藥
  • 植物藥
  • 標準化植物藥
  • 植物研究的臨床試驗材料

第7章：市場規模及預測：依種植方式分類，2021-2034年

• 主要趨勢
• 傳統耕作方式
• 有機種植
• 受控環境農業

第8章：市場規模及預測：依地區分類，2021-2034年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第9章：公司簡介

• Cargill
• Kemin
• Aries Agro
• Americas Heartland
• Neutragen Healthcare
• Corteva Agriscience
• Bayer Crop Science
• Syngenta Group
• AeroFarms

The Global Specialty Crops for Nutraceuticals Market was valued at USD 21.8 billion in 2024 and is estimated to grow at a CAGR of 9.8% to reach USD 56.6 billion by 2034.

The expansion is fueled by rising global awareness around preventive health and a growing shift toward natural, plant-based wellness alternatives. Specialty crops, including nutrient-dense fruits, seeds, nuts, vegetables, and medicinal herbs, are being cultivated specifically for their bioactive properties and health benefits. These crops are not only used in functional foods and dietary supplements but are also gaining traction in pharmaceutical formulations, where agriculture increasingly intersects with health science. The momentum is being driven by consumers who now view food as medicine and are increasingly seeking targeted, natural solutions for long-term wellness. Demand continues to surge for ingredients perceived as immune-enhancing or stress-reducing. This interest has been amplified in recent years by global health challenges and is sustained by evolving farming practices like precision agriculture and controlled environment cultivation that allow consistent year-round harvesting. With government dietary recommendations and research institutions emphasizing whole-food nutrition, the role of specialty crops in the nutraceuticals space is becoming central to global wellness strategies.

The medicinal herbs and botanicals segment will reach USD 21.1 billion by 2034. Their widespread use stems from both traditional medicine systems and increasing validation from scientific research. Modern consumers are gravitating toward herbal-based remedies for managing stress, boosting immunity, and supporting long-term health. This segment continues to lead, backed by a consumer base that prefers natural over synthetic solutions and trusts botanical efficacy. Several herbal varieties known for supporting cognitive function, energy, and immunity have seen explosive growth in supplement applications, contributing significantly to overall market expansion.

The dietary supplements segment held a 65% share in 2024 and is forecasted to grow to USD 36.8 billion by 2034. This growth is driven by consumers shifting from generic multivitamins to targeted, plant-based formulations designed for specific health outcomes such as metabolism, brain function, and mobility. Ingredient traceability, cleaner labels, and high bioavailability have become major purchase drivers. Leading supplement manufacturers are forming strategic alliances with specialty crop producers to guarantee consistent quality and build vertically integrated supply chains. This helps ensure transparency, sustainability, and reliability, which resonate with health-conscious consumers.

U.S. Specialty Crops for Nutraceuticals Market was valued at USD 7.2 billion in 2024 and is expected to reach USD 14.16 billion by 2034. The region benefits from cutting-edge agriculture technologies, robust research capabilities, and a mature market for premium health products. States like Washington, Oregon, and California are seeing rising cultivation of high-value specialty crops focused on health-based use. The push for organic farming practices and sustainability is accelerating acreage expansion. Health-aware consumers in the U.S. are also increasingly demanding locally grown, traceable ingredients, creating opportunities for domestic growers to diversify into botanicals and functional plant-based products that meet high market standards.

Key players in the Specialty Crops for Nutraceuticals Market include Kemin, Neutragen Healthcare, Americas Heartland, Aries Agro, and Cargill. Companies in the Specialty Crops for Nutraceuticals Market are prioritizing vertical integration by investing directly in farming partnerships to secure consistent, high-quality raw materials. Many are leveraging advanced agricultural practices such as CEA (Controlled Environment Agriculture) and precision farming to ensure year-round availability and enhance yield efficiency. A major strategic focus lies in developing proprietary crop varieties rich in targeted bioactives, aligning closely with clinical research to support health claims. Businesses are expanding product portfolios with clean-label, single-ingredient supplements tailored for specific wellness goals. Certifications such as organic, non-GMO, and sustainably farmed are being used to differentiate offerings and build trust. Branding efforts increasingly highlight traceability, and companies are deepening R&D investment to link botanical efficacy with measurable health outcomes.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Product type
  • 2.2.2 Application
  • 2.2.3 Cultivation method
• 2.3 TAM analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
  • 3.6.1 Technology and innovation landscape
  • 3.6.2 Current technological trends
  • 3.6.3 Emerging technologies
• 3.7 Price trends
  • 3.7.1 By region
• 3.8 Future market trends
• 3.9 Technology and innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent landscape
• 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint considerations

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 Latin America
    • 4.2.1.5 Middle East & Africa
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Size and Forecast, By Product Type, 2021-2034 (USD Billion) (Kilo Tons)

• 5.1 Key trends
• 5.2 Medicinal herbs & botanicals
  • 5.2.1 Adaptogenic herbs
  • 5.2.2 Traditional medicinal plants
  • 5.2.3 Anti-inflammatory botanicals
  • 5.2.4 Others
• 5.3 Functional fruits & berries
  • 5.3.1 Antioxidant-rich berries
  • 5.3.2 Citrus fruits for flavonoids
  • 5.3.3 Exotic fruits
• 5.4 Tree nuts & seeds
  • 5.4.1 Omega-rich nuts
  • 5.4.2 Protein-rich seeds
  • 5.4.3 Specialty nuts
• 5.5 Culinary herbs & spices
  • 5.5.1 Anti-inflammatory spices
  • 5.5.2 Aromatic herbs
  • 5.5.3 Exotic spices
• 5.6 Functional vegetables
  • 5.6.1 Carotenoid-rich vegetables
  • 5.6.2 Cruciferous vegetables
  • 5.6.3 Allium vegetables

Chapter 6 Market Size and Forecast, By Application, 2021-2034 (USD Billion) (Kilo Tons)

• 6.1 Key trends
• 6.2 Dietary supplements
  • 6.2.1 Single-ingredient supplements
  • 6.2.2 Multi-ingredient formulations
  • 6.2.3 Targeted health supplements
• 6.3 Functional foods & beverages
  • 6.3.1 Fortified foods with specialty crop extracts
  • 6.3.2 Functional beverages
  • 6.3.3 Probiotic foods enhanced with prebiotic specialty crops
• 6.4 Pharmaceutical
  • 6.4.1 Botanical drugs
  • 6.4.2 Standardized plant medicines
  • 6.4.3 Clinical trial materials for botanical research

Chapter 7 Market Size and Forecast, By Cultivation Method, 2021-2034 (USD Billion) (Kilo Tons)

• 7.1 Key trends
• 7.2 Conventional cultivation
• 7.3 Organic cultivation
• 7.4 Controlled environment agriculture

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Billion) (Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 UK
  • 8.3.2 Germany
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Cargill
• 9.2 Kemin
• 9.3 Aries Agro
• 9.4 Americas Heartland
• 9.5 Neutragen Healthcare
• 9.6 Corteva Agriscience
• 9.7 Bayer Crop Science
• 9.8 Syngenta Group
• 9.9 AeroFarms